A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

Autor: Matthew H. Kulke, Haesook Kim, Jeffrey W. Clark, Peter C. Enzinger, Thomas J. Lynch, Jeffrey A. Morgan, Michele Vincitore, Ann Michelini, Charles S. Fuchs
Zdroj: Cancer (0008543X); Sep2004, Vol. 101 Issue 5, p934-939, 6p
Databáze: Complementary Index
Externí odkaz: